Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33,235,472
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
17,503,080
-
Shares change
-
-166,990
-
Total reported value, excl. options
-
$78,589,150
-
Value change
-
-$756,243
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$4.49
Significant Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q2 2023
23 filings reported holding NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share as of Q2 2023.
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,503,080 shares
of 33,235,472 outstanding shares and own 53% of the company stock.
Largest 10 shareholders include KCK LTD. (5,621,111 shares), ORBIMED ADVISORS LLC (4,012,281 shares), Soleus Capital Management, L.P. (2,466,214 shares), MORGAN STANLEY (2,358,866 shares), FMR LLC (1,223,663 shares), MILLENNIUM MANAGEMENT LLC (628,933 shares), Nantahala Capital Management, LLC (424,850 shares), VANGUARD GROUP INC (378,187 shares), Kent Lake Capital LLC (149,205 shares), and GEODE CAPITAL MANAGEMENT, LLC (71,515 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.